Non classé
16 February is World Cholangiocarcinoma Day
DiCE is proud to support GCCA’s international effort to raise much-needed awareness of CCA, devastating cancer that occurs in the bile ducts in o...
First Immunotherapy Drug Durvalumab Plus Chemotherapy Approved in Europe for Advanced Biliary Cancer
On 21 December the European Commission (EC) approved the use of durvalumab (Imfinzi ®) plus chemotherapy (gemcitabine plus cisplatin) as the first...
Trastuzumab Deruxtecan Approved as Second-line Treatment in Europe For Patients With HER2-positive Advanced Gastric Cancer
On December 19th the European Commission (EC) approved the use of trastuzumab deruxtecan (Enhertu ®) plus chemotherapy (gemcitabine plus cisplatin...
Nutrition Position Paper
Nutritional intervention is essential to cancer treatments. It can reduce hospitalisation length and treatment-related toxicity while improving nut...
National Cancer Center Japan Asks for Your Support on a Project to Impact Patient Engagement
Would you like to know how and where patient engagement is happening in R&D? Would you like to see an objective comparison between Europe and J...
Digestive Health Community Support for the Proposed EU Cancer Screening Recommendations
DiCE and United European Gastroenterology (UEG) issued a letter of support for the European Commission’s proposal.
...My Food Podcast
...
- « Previous Page
- 1
- ...
- 3
- 4
- 5
- 6
- 7
- Next Page »
